<DOC>
	<DOC>NCT01076374</DOC>
	<brief_summary>The primary purpose of this study is to assess the long term reliability of the Medtronic Adapta®/Sensia™/Versa™ platform of devices. This study is required by FDA as a condition of approval of nEw3 devices. Patients will be followed for 5 years after implant. This study utilizes data collected from the System Longevity Study (SLS).</brief_summary>
	<brief_title>nEw3 Post-approval Study</brief_title>
	<detailed_description>The rate of device malfunctions will be determined and a comparison to historical controls will be done.</detailed_description>
	<mesh_term>Bradycardia</mesh_term>
	<criteria>Subjects or appropriate legal guardians provide written informed consent and/or authorization for access to and use of health information, as required by an institution's IRB/MEC/REB. AND one of the following must also apply: Subjects indicated for implant or within six months postimplant of a Medtronic marketreleased lead connected to a Medtronic Adapta®, Sensia™, or Versa™ IPG. The Medtronic lead must be used for pacing, sensing or defibrillation application. Subjects who participated in a qualifying study (IDE) of a Medtronic cardiac therapy product and: 1) have a Medtronic Adapta®, Sensia™, or Versa™ IPG 2)product is marketreleased 3) complete implant and followup data, including productrelated adverse events are available and 4) subject of appropriate legal guardian authorizes release of subject study data to SLS Subjects implanted with a Medtronic Adapta®, Sensia™, or Versa™ IPG and Medtronic CapSure Epi Leads (model 4965 and 4968) at a minimum of three preselected sites to retrospectively collect data for post approval requirements. Subjects who are, or will be inaccessible for followup at a SLS center Subjects with exclusion criteria required by local law (EMEA only) Subjects receiving an implant of a Medtronic device at a nonparticipating center and the implant data and current status cannot be confirmed within 30 days after implant Subjects implanted with a Medtronic device whose predetermined enrollment limit for that specific product has been exceeded</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>pacemaker</keyword>
</DOC>